High Prevalence of Cancer and Other Chronic Conditions to Bode Well for the Peptide Therapeutics Market, However, Steep Cost of New Therapeutic Development Could Stifle Market Growth, Says TMR
(0) - Since the geriatric population is more susceptible to various chronic conditions, the global peptide therapeutics market is expected to expand at a rapid pace. - Technological advances have helped to reduce the overall costs associated with the making of therapeutic peptides, encouraging producers and manufacturers to look for new ways to produce therapeutic peptides. ALBANY, N.Y., April 13, 2021 /PRNewswire/ -- The global peptide therapeutics market is expected to expand due to the high prevalence and incidence of metabolic disorders. Furthermore, the said market is anticipated to be d...